dc.contributor
[Buonsenso D] From the Department of Woman and Child Health and Public Health, Fondazione Policlnico Universitario A. Gemelli IRCCS, Rome, Italy. Centro di Salute Globale, Università Cattolica del Sacro Cuore, Roma, Italy. [Perramon A] Department of Physics, Universitat Politècnica de Catalunya (UPC·BarcelonaTech), Barcelona, Catalonia, Spain. [Català M] Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom. [Torres JP] Department of Paediatrics, Division of Paediatric Infectious Diseases, Hospital Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago de Chile, Chile. [Camacho-Moreno G] Paediatric Infectious Diseases Unit, HOMI, Fundación Hospital Pediátrico la Misericordia, Universidad Nacional de Colombia, Bogotá, Colombia. [Rojas-Solano M] Unidad de Vigilancia Epidemiológica. [Martínez-Mejias A] Servei de Pediatria, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain
dc.contributor
Consorci Sanitari de Terrassa
dc.contributor.author
Buonsenso, Danilo
dc.contributor.author
Perramon, Aida
dc.contributor.author
Català, Martí
dc.contributor.author
Torres, Juan P
dc.contributor.author
Camacho, Germán
dc.contributor.author
Rojas-Solano, Mariela
dc.contributor.author
MARTINEZ-MEJIAS, ABEL
dc.date.accessioned
2025-10-24T08:28:13Z
dc.date.available
2025-10-24T08:28:13Z
dc.date.issued
2023-08-02T10:59:36Z
dc.date.issued
2023-08-02T10:59:36Z
dc.date.issued
2022-12-01
dc.identifier
Buonsenso D, Perramon A, Català M, Torres JP, Camacho-Moreno G, Rojas-Solano M, et al, Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study. Pediatr Infect Dis J. 2022 Dec 1;41(12):989-93.
dc.identifier
https://hdl.handle.net/11351/10044
dc.identifier
10.1097/INF.0000000000003713
dc.identifier.uri
http://hdl.handle.net/11351/10044
dc.description.abstract
COVID-19, Multisystemic inflammatory syndrome; Children; Epidemiology
dc.description.abstract
COVID-19, Síndrome inflamatorio multisistémico; Niños; Epidemiología
dc.description.abstract
COVID-19, Síndrome inflamatòria multisistèmica; Nens; Epidemiologia
dc.description.abstract
Background: SARS-CoV-2 variations as well as immune protection after previous infections and/or vaccination may have altered the incidence of multisystemic inflammatory syndrome in children (MIS-C). We aimed to report an international time-series analysis of the incidence of MIS-C to determine if there was a shift in the regions or countries included into the study.
Methods: This is a multicenter, international, cross-sectional study. We collected the MIS-C incidence from the participant regions and countries for the period July 2020 to November 2021. We assessed the ratio between MIS-C cases and COVID-19 pediatric cases in children <18 years diagnosed 4 weeks earlier (average time for the temporal association observed in this disease) for the study period. We performed a binomial regression analysis for 8 participating sites [Bogotá (Colombia), Chile, Costa Rica, Lazio (Italy), Mexico DF, Panama, The Netherlands and Catalonia (Spain)].
Results: We included 904 cases of MIS-C, among a reference population of 17,906,432 children. We estimated a global significant decrease trend ratio in MIS-C cases/COVID-19 diagnosed cases in the previous month ( P < 0.001). When analyzing separately each of the sites, Chile and The Netherlands maintained a significant decrease trend ( P < 0.001), but this ratio was not statistically significant for the rest of sites.
Conclusions: To our knowledge, this is the first international study describing a global reduction in the trend of the MIS-C incidence during the pandemic. COVID-19 vaccination and other factors possibly linked to the virus itself and/or community transmission may have played a role in preventing new MIS-C cases.
dc.format
application/pdf
dc.publisher
Lippincott, Williams & Wilkins
dc.relation
The Pediatric Infectious Disease Journal;41(12)
dc.relation
https://doi.org/10.1097/inf.0000000000003713
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
COVID-19 (Malaltia) - Vacunació
dc.subject
DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections
dc.subject
CHEMICALS AND DRUGS::Complex Mixtures::Biological Products::Vaccines
dc.subject
NAMED GROUPS::Persons::Age Groups::Child
dc.subject
ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos::vacunas
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
dc.title
Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion